The Executive Committee
David K. Lee
Executive Vice President, USA
David K. Lee joined Servier in 2018 to lead Servier’s operations in the United States. In January 2025, he was appointed to the Executive Committee as Executive Vice President, U.S. with an expanded role that also involves leading strategic initiatives for the Group globally. In this capacity, David K. Lee will oversee the continued growth of Servier in the United States — currently the Group’s largest subsidiary, driven by its success in oncology — while contributing to the Group’s broader global strategy.
Before joining Servier, David K. Lee held leadership roles at several industry-leading companies, including Baxter, GSK, Novartis and Shire. At Shire, David K. Lee served as Global Head of the Rare Diseases and Oncology franchises, where he led cross-functional teams responsible for strategy, marketing, business development, R&D, and support functions.
David K. Lee played a pivotal role in Servier’s acquisition of Shire’s Oncology portfolio and later Agios’ Oncology division, contributing to the successful integration of their teams and assets into the Group.
David K. Lee earned a Bachelor of Science in Biochemistry from Harvard University and an MBA from Harvard Business School.
